New Publication

IMATHERA (CGFL, Dr Bertand Collin, Associate Professor, ICMUB – UMR CNRS 6302) was present at the “5ème Journées Scientifiques du GDR Agents d’Imagerie Moléculaire (GDR AIM)” in Paris. Romain Fontaine-Tuffery (ICMUB – UMR CNRS 6302/CGFL) presented his research work as part of the EQUIPEX IMAPPI (ANR-10-EQPX-0005) on the synthesis of fluorinated metal porphyrin platforms for PET imaging and photodynamic therapy. This work is under the direction of Dr Bertrand Collin (CGFL/ICMUB) and Dr Richard Decreau (Associate Professor, ICMUB – UMR CNRS 6302).

IMATHERa (CGFL, Dr Bertand Collin, ICMUB – UMR CNRS 6302) was present at the “Journées de recherche respiratoires (J2R)” in Tours. Dr Alexandre Dias (CGFL) presented his research work as part of the HYMAGE-IPF project (ANR-20-CE17-0005) on the development of a theranostic strategy targeting Gp96 in pulmonary fibrosis. This work, under the direction of Dr Pierre-Simon Bellaye (CGFL), was carried out in collaboration with Pr Philippe Bonniaud’s (CHU de Dijon – INSERM U1231, HSP-pathies) team led by Dr Carmen Garrido (INSERM U1231, HSP-pathies).

IMATHERa (CGFL) was present at the European Congress of Nuclear Medicine (EANM) in Vienna. Drs Alan Courteau and Bertrand Collin (CGFL / ICMUB – UMR CNRS 6302) presented their research work part of the EQUIPEX IMAPPI (ANR-10-EQPX-0005) program on preclinical multi-animal PET/MRI imaging and preclinical theranostic PET imaging of CD30-positive cancers with [Zr89]Zr-DFO-Brentuximab vedotin, respectively.

A new review article, co-authored by Drs Jame Frenay and Pierre-Simon Bellaye (Supervisor: Dr Alexandre Dias), has just been published by IMATHERa (CGFL – Dr B. Collin, ICMUB UMR CNRS 6302). This literature review highlights the fact that IL-1RAP, a receptor involved in the inflammatory response, is now considered as a promising therapeutic target in several hematological and solid cancers: see publication.

A new review article, co-authored by Drs Alexandre Dias and Alan Courteau, has just been published by IMATHERa (CGFL – Dr B. Collin, ICMUB UMR CNRS 6302).

This literature review highlights the theranostic potential of innovative superparamagnetic nanoparticles for cancer immunotherapy via magnetic hyperthermia and targeting of M2 macrophages: https://www.mdpi.com/1999-4923/14/11/2388.